VPS13A Antibody

What is VPS13A and why is it significant in research?

VPS13A (vacuolar protein sorting 13 homolog A) is a high molecular weight protein (360.3 kDa) also known as Chorein, CHAC, or chorea-acanthocytosis protein. It is significant in research because mutations in the VPS13A gene cause chorea-acanthocytosis (ChAc), a rare neurodegenerative disorder characterized by hyperkinetic movements, cognitive abnormalities, and the presence of acanthocytes (spiky red blood cells). VPS13A functions as a peripheral membrane protein associated with multiple organelles, including mitochondria, the endoplasmic reticulum (ER), and lipid droplets, playing crucial roles in inter-organelle lipid transport at membrane contact sites .

What are the common applications for VPS13A antibodies in research?

VPS13A antibodies are primarily used for:

• Western blot (WB) analysis to detect VPS13A protein expression and confirm ChAc diagnosis

• Immunohistochemistry (IHC) to examine tissue distribution patterns

• Immunofluorescence (IF) to study subcellular localization

• Co-immunoprecipitation (Co-IP) to investigate protein-protein interactions

• Enzyme-linked immunosorbent assay (ELISA) for protein quantification

Most commercially available antibodies are validated for WB at dilutions of 1:500-1:1000 and IHC at dilutions of 1:50-1:500 .

How is VPS13A protein typically detected in experimental settings?

Detection of VPS13A protein typically involves:

• Western blot analysis using specific antibodies targeting different epitopes (N-terminal, middle, or C-terminal regions)

• Peripheral blood sample preparation from patients or cell lysates from cultured cells

• Fractionation techniques to separate membrane-associated and cytosolic fractions

• Densitometry analysis to quantify protein levels

In diagnostic settings for ChAc, the absence of VPS13A protein bands in Western blots using antibodies targeting different epitopes confirms the diagnosis. For example, antibodies like Anti-VPS13A (HPA021662, Sigma-Aldrich) targeting a C-terminal epitope and Anti-VPS13A (PA5-54483, Invitrogen) targeting a middle epitope are used in tandem to verify complete protein absence .

How should one optimize Western blot protocols for detecting VPS13A?

Optimizing Western blot protocols for VPS13A detection requires:

• Sample preparation considerations:

  • Use fresh samples when possible

  • Include protease inhibitors to prevent degradation

  • For membrane fractionation: high-speed centrifugation (100,000×g) helps separate membrane-bound VPS13A from cytosolic proteins

• Gel electrophoresis optimization:

  • Use low percentage gels (6-8%) to resolve the large 360 kDa protein

  • Extend running time to ensure proper separation

• Transfer parameters:

  • Employ wet transfer methods with extended transfer times (overnight at low voltage)

  • Use PVDF membranes rather than nitrocellulose for better retention

• Antibody selection and dilution:

  • Primary antibody dilution: typically 1:500-1:1000

  • Secondary antibody: HRP-conjugated or fluorescent, depending on detection system

  • Consider using multiple antibodies targeting different epitopes for verification

• Detection system:

  • Enhanced chemiluminescence (ECL) with extended exposure times

  • For low abundance samples, consider using more sensitive substrates

What are the key considerations for immunohistochemical detection of VPS13A?

For effective immunohistochemical detection of VPS13A:

• Tissue preparation:

  • Fresh frozen or properly fixed paraffin-embedded tissues

  • For paraffin sections, antigen retrieval is crucial using either:

    • TE buffer pH 9.0 (recommended)

    • Citrate buffer pH 6.0 (alternative)

• Antibody selection:

  • Use antibodies validated for IHC applications (e.g., HPA021662 or HPA021652)

  • Working dilution range: 1:50-1:500 for most commercial antibodies

• Controls:

  • Include positive controls (e.g., brain tissue, kidney tissue)

  • Use VPS13A knockout tissues as negative controls when available

• Signal amplification:

  • Consider tyramide signal amplification for low abundance targets

  • Use polymer-based detection systems for enhanced sensitivity

• Counterstaining:

  • Light hematoxylin counterstaining to visualize tissue architecture

  • Avoid excessive counterstaining that might mask specific signals

What approaches are recommended for studying VPS13A subcellular localization?

To effectively study VPS13A subcellular localization:

• Immunofluorescence microscopy:

  • Co-staining with organelle markers:

    • Mitochondria: MitoTracker or antibodies against TOMM20

    • ER: antibodies against markers like Sec61B or VAP-A

    • Lipid droplets: BODIPY, LipidTOX, or Nile Red staining

  • Use high-resolution imaging (confocal or super-resolution microscopy)

• Subcellular fractionation:

  • Differential centrifugation to isolate organelle fractions

  • Density gradient separation for purified organelles

  • Western blot analysis of fractions using organelle markers alongside VPS13A

• Proximity labeling approaches:

  • BioID or APEX2 fusions to VPS13A to identify proximal proteins

  • Analyze labeled proteins by mass spectrometry

• Live cell imaging:

  • GFP-tagged VPS13A constructs for dynamic localization studies

  • Photobleaching techniques (FRAP) to assess protein mobility

How do VPS13A domains influence its localization and function?

VPS13A contains several functional domains that influence its localization and function:

To experimentally analyze these domains:

• Generate domain deletion or point mutation constructs

• Express constructs in cells and assess localization by microscopy

• Perform co-immunoprecipitation with interacting partners

• Conduct rescue experiments in VPS13A knockout models

What methods are available for studying VPS13A protein-protein interactions?

Several methods are available for studying VPS13A protein-protein interactions:

• Co-immunoprecipitation:

  • Use anti-VPS13A antibodies to pull down protein complexes

  • Analyze by Western blot or mass spectrometry

  • Example: This approach identified VAP-A as an interactor through the FFAT motif

• GST pull-down assays:

  • Generate GST-tagged VPS13A fragments

  • Incubate with cell lysates or purified proteins

  • Analyze bound proteins by Western blot

  • Example: GST-VPS13A fragments containing the FFAT motif pulled down VAP-A

• Yeast two-hybrid screening:

  • Use VPS13A domains as bait to identify novel interactors

  • Validate interactions by orthogonal methods

• Proximity labeling:

  • BioID or APEX2 fusions to identify proteins in close proximity

  • Analyze biotinylated proteins by mass spectrometry

• AlphaFold modeling and validation:

  • Model protein structures and interaction interfaces

  • Test predictions with mutagenesis

  • Example: AlphaFold modeling predicted interaction surfaces between VPS13A and XK protein

How can VPS13A antibodies be used to study disease mechanisms in chorea-acanthocytosis?

VPS13A antibodies are essential tools for studying ChAc disease mechanisms:

• Diagnostic applications:

  • Western blot analysis to confirm VPS13A protein absence in patient samples

  • Use multiple antibodies targeting different epitopes to detect possible truncated forms

• Disease modeling validation:

  • Verify VPS13A knockout in CRISPR/Cas9-generated cell lines

  • Confirm protein depletion in siRNA knockdown experiments

• Protein restoration studies:

  • Monitor VPS13A expression in gene therapy approaches

  • Quantify protein levels following treatment with compounds that may stabilize mutant proteins

• Biomarker development:

  • Correlate VPS13A protein levels with disease severity

  • Investigate post-translational modifications using modification-specific antibodies

• Pathology mechanism studies:

  • Examine VPS13A localization changes in disease states

  • Investigate relationships between VPS13A and other proteins implicated in neurodegeneration

What approaches can address the challenges of detecting low-abundance or mutant VPS13A proteins?

Detecting low-abundance or mutant VPS13A proteins requires specialized approaches:

• Enhanced sensitivity Western blot protocols:

  • Use high-sensitivity chemiluminescent substrates

  • Employ signal enhancement systems like biotin-streptavidin amplification

  • Increase protein loading (50-100 μg) and extend exposure times

• Immunoprecipitation before detection:

  • Concentrate VPS13A protein by immunoprecipitation

  • Perform Western blot on the enriched sample

• Multiple epitope targeting:

  • Use antibodies recognizing different regions of VPS13A

  • For example, combine antibodies targeting N-terminal, middle, and C-terminal regions

  • This approach can detect truncated proteins resulting from mutations

• Mass spectrometry-based detection:

  • Targeted proteomics approaches (SRM/MRM)

  • Immunoprecipitation followed by mass spectrometry

• Proximity ligation assay (PLA):

  • Detect protein-protein interactions involving VPS13A with higher sensitivity

  • Useful for visualizing low-abundance complexes in situ

How do I troubleshoot inconsistent results when using VPS13A antibodies across different experimental systems?

When facing inconsistent results with VPS13A antibodies:

• Antibody validation:

  • Verify antibody specificity using VPS13A knockout or knockdown controls

  • Test multiple antibodies targeting different epitopes

  • Check cross-reactivity with other VPS13 family members (VPS13B, VPS13C, VPS13D)

• Sample preparation optimization:

  • Ensure complete cell lysis for membrane-associated proteins

  • Test different lysis buffers (RIPA vs. NP-40 vs. digitonin-based)

  • Add protease inhibitors to prevent degradation

  • For membrane proteins, avoid freeze-thaw cycles

• Species-specific considerations:

  • Confirm antibody reactivity with your species of interest

  • Most VPS13A antibodies are validated for human and mouse samples

  • Check epitope conservation across species

• Technical parameters:

  • For Western blot: Optimize gel percentage, transfer conditions, and blocking agents

  • For IHC: Test different antigen retrieval methods (pH 6.0 vs. pH 9.0 buffers)

  • For IP: Try different bead types and washing stringencies

• Expression level variations:

  • Account for tissue-specific expression patterns

  • Consider developmental stage differences

  • Note cell line variations in VPS13A expression

How can VPS13A antibodies be used to study membrane contact sites and lipid transport?

VPS13A antibodies can facilitate the study of membrane contact sites and lipid transport:

• Visualizing contact sites:

  • Immunofluorescence to detect VPS13A at mitochondria-ER contacts

  • Super-resolution microscopy to resolve distinct contact site populations

  • Correlative light and electron microscopy to link protein localization with ultrastructure

• Biochemical isolation of contact sites:

  • Use VPS13A antibodies for immunoprecipitation of contact site complexes

  • Analyze associated proteins and lipids by mass spectrometry

• Lipid transfer assays:

  • Monitor lipid transport between organelles in the presence or absence of VPS13A

  • Correlate VPS13A levels with lipid distribution using lipidomics approaches

• In vitro reconstitution:

  • Immunoisolate VPS13A-containing complexes for functional studies

  • Test lipid transfer capabilities using artificial membrane systems

• Dynamic studies:

  • Track VPS13A movement between organelles during cellular responses

  • Correlate with changes in membrane composition

What are the methodological approaches for comparing VPS13A with other VPS13 family members?

To compare VPS13A with other VPS13 family members (VPS13B, VPS13C, and VPS13D):

• Antibody specificity verification:

  • Test cross-reactivity of VPS13A antibodies with other family members

  • Use knockout/knockdown controls for each family member

  • Design experiments with multiple antibodies targeting unique epitopes

• Comparative localization studies:

  • Perform co-localization studies using antibodies specific to each family member

  • Analyze distribution patterns across different organelles

  • Examine potential co-localization or mutual exclusion

• Functional complementation experiments:

  • Express different family members in VPS13A knockout models

  • Assess rescue of phenotypes (lipid droplet formation, mitochondrial morphology)

  • Identify shared vs. unique functions

• Domain swap analysis:

  • Create chimeric proteins between VPS13A and other family members

  • Map functional domains responsible for specific localizations or interactions

  • Test activity in relevant cellular assays

• Comparative proteomics:

  • Immunoprecipitate each family member and compare interactomes

  • Identify common and unique binding partners

  • Correlate with functional differences

How can advanced imaging techniques enhance VPS13A research using specific antibodies?

Advanced imaging techniques can significantly enhance VPS13A research:

• Super-resolution microscopy:

  • STED, STORM, or PALM imaging of antibody-labeled VPS13A

  • Resolve VPS13A distribution at membrane contact sites with 20-50 nm resolution

  • Quantify precise distances between VPS13A and other proteins

• Live-cell imaging approaches:

  • Combine antibody fragments (Fab, nanobodies) with cell-permeable tags

  • Track dynamic changes in VPS13A localization during cellular processes

  • Correlate with organelle movements using specific markers

• FRET/FLIM analysis:

  • Use fluorescently labeled antibodies or tagged VPS13A constructs

  • Measure molecular proximity between VPS13A and interacting partners

  • Detect conformational changes upon binding to different membranes

• Correlative light and electron microscopy (CLEM):

  • Combine fluorescence microscopy of antibody-labeled VPS13A with EM

  • Correlate protein localization with ultrastructural features

  • Visualize membrane contact sites at nanometer resolution

• Expansion microscopy:

  • Physically expand samples to improve resolution of conventional microscopes

  • Reveal fine details of VPS13A distribution not visible with standard confocal imaging

  • Study spatial relationships between VPS13A and cellular structures